Parkinson's disease – the continuing search for biomarkers
Identifieur interne : 000205 ( Main/Exploration ); précédent : 000204; suivant : 000206Parkinson's disease – the continuing search for biomarkers
Auteurs : David P. Breen ; Andrew W. Michell ; Roger A. BarkerSource :
- Clinical Chemistry and Laboratory Medicine [ 1434-6621 ] ; 2011-03-01.
Abstract
There is currently no well-established biomarker for Parkinson's disease. The need to better diagnose the condition, define the subtypes of disease, and follow its course independent of any symptomatic drug effects is well-established. In this review, we will begin by reviewing the evidence for biological fluid biomarkers in Parkinson's disease. We will then touch upon the role of brain imaging in diagnosis and defining prognosis, as well as the value of studying motor phenotype and its potential applications for characterising Parkinson's disease subtypes with differing natural histories.
Url:
DOI: 10.1515/CCLM.2011.080
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Parkinson's disease – the continuing search for biomarkers</title><author><name sortKey="Breen, David P" sort="Breen, David P" uniqKey="Breen D" first="David P." last="Breen">David P. Breen</name></author><author><name sortKey="Michell, Andrew W" sort="Michell, Andrew W" uniqKey="Michell A" first="Andrew W." last="Michell">Andrew W. Michell</name></author><author><name sortKey="Barker, Roger A" sort="Barker, Roger A" uniqKey="Barker R" first="Roger A." last="Barker">Roger A. Barker</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:BF2B38A1707C49B0B452E11282F7EAAAD72AF283</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1515/CCLM.2011.080</idno><idno type="url">https://api.istex.fr/document/BF2B38A1707C49B0B452E11282F7EAAAD72AF283/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000210</idno><idno type="wicri:Area/Main/Curation">000173</idno><idno type="wicri:Area/Main/Exploration">000205</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Parkinson's disease – the continuing search for biomarkers</title><author><name sortKey="Breen, David P" sort="Breen, David P" uniqKey="Breen D" first="David P." last="Breen">David P. Breen</name></author><author><name sortKey="Michell, Andrew W" sort="Michell, Andrew W" uniqKey="Michell A" first="Andrew W." last="Michell">Andrew W. Michell</name></author><author><name sortKey="Barker, Roger A" sort="Barker, Roger A" uniqKey="Barker R" first="Roger A." last="Barker">Roger A. Barker</name></author></analytic><monogr></monogr><series><title level="j">Clinical Chemistry and Laboratory Medicine</title><idno type="ISSN">1434-6621</idno><idno type="eISSN">1437-4331</idno><imprint><publisher>Walter de Gruyter</publisher><date type="published" when="2011-03-01">2011-03-01</date><biblScope unit="volume">49</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="393">393</biblScope><biblScope unit="page" to="401">401</biblScope></imprint><idno type="ISSN">1434-6621</idno></series><idno type="istex">BF2B38A1707C49B0B452E11282F7EAAAD72AF283</idno><idno type="DOI">10.1515/CCLM.2011.080</idno><idno type="ArticleID">cclm.2011.080</idno><idno type="Related-article-Href">cclm.2011.080.pdf</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1434-6621</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">There is currently no well-established biomarker for Parkinson's disease. The need to better diagnose the condition, define the subtypes of disease, and follow its course independent of any symptomatic drug effects is well-established. In this review, we will begin by reviewing the evidence for biological fluid biomarkers in Parkinson's disease. We will then touch upon the role of brain imaging in diagnosis and defining prognosis, as well as the value of studying motor phenotype and its potential applications for characterising Parkinson's disease subtypes with differing natural histories.</div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Barker, Roger A" sort="Barker, Roger A" uniqKey="Barker R" first="Roger A." last="Barker">Roger A. Barker</name><name sortKey="Breen, David P" sort="Breen, David P" uniqKey="Breen D" first="David P." last="Breen">David P. Breen</name><name sortKey="Michell, Andrew W" sort="Michell, Andrew W" uniqKey="Michell A" first="Andrew W." last="Michell">Andrew W. Michell</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000205 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000205 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:BF2B38A1707C49B0B452E11282F7EAAAD72AF283
|texte= Parkinson's disease – the continuing search for biomarkers
}}
| This area was generated with Dilib version V0.6.23. |  |